Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. – Cost Effective Supplements

Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/22981952

Conclusion of this study

Exclusively or predominantly breastfed infants with infantile colic benefit from the administration of L reuteri DSM 17938 compared with placebo.

Supplements analyzed in this study

Lactobacillus reuteri

Health conditions analyzed in this study

Colic and crying

Slightly Positive

Lactobacillus reuteri

Functions related to this study

Digestion

Slightly Positive

Lactobacillus reuteri

Body systems related to this study

Digestive System

Lactobacillus reuteri